Cannabinoid compounds like Cannabidiol (CBD) show promising potential in treating various diseases.
Kannalife Sciences Inc. (now Neuropathix Inc.) is a leading company in researching and developing novel cannabinoid compounds. By optimizing the molecular structure of CBD, Kannalife has been able to increase efficacy while reducing side effects.
This scientific explainer video sheds light on the development of the patented molecule KLS-13019, showcasing its diverse benefits and applications. Its potential in preventing chemotherapy-induced peripheral neuropathy is particularly promising.
